The neurochemical mechanism of rebound psychosis in Parkinson's disease
Identifieur interne : 003708 ( Main/Exploration ); précédent : 003707; suivant : 003709The neurochemical mechanism of rebound psychosis in Parkinson's disease
Auteurs : Spiridon Papapetropoulos [États-Unis] ; Deborah C. Mash [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-04.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Clozapine, Dibenzothiazepines.
- drug therapy : Psychotic Disorders.
- etiology : Psychoses, Substance-Induced, Psychotic Disorders.
- psychology : Parkinson Disease.
- Humans.
Abstract
A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.
Url:
DOI: 10.1002/mds.20438
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004200
- to stream Istex, to step Curation: 004200
- to stream Istex, to step Checkpoint: 002114
- to stream PubMed, to step Corpus: 003110
- to stream PubMed, to step Curation: 003110
- to stream PubMed, to step Checkpoint: 002F40
- to stream Ncbi, to step Merge: 001191
- to stream Ncbi, to step Curation: 001191
- to stream Ncbi, to step Checkpoint: 001191
- to stream Main, to step Merge: 004D91
- to stream Main, to step Curation: 003708
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title><author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name></author><author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FE0693A54A21F8639CB502365BC025523F49A883</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20438</idno><idno type="url">https://api.istex.fr/document/FE0693A54A21F8639CB502365BC025523F49A883/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004200</idno><idno type="wicri:Area/Istex/Curation">004200</idno><idno type="wicri:Area/Istex/Checkpoint">002114</idno><idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15747367</idno><idno type="wicri:Area/PubMed/Corpus">003110</idno><idno type="wicri:Area/PubMed/Curation">003110</idno><idno type="wicri:Area/PubMed/Checkpoint">002F40</idno><idno type="wicri:Area/Ncbi/Merge">001191</idno><idno type="wicri:Area/Ncbi/Curation">001191</idno><idno type="wicri:Area/Ncbi/Checkpoint">001191</idno><idno type="wicri:doubleKey">0885-3185:2005:Papapetropoulos S:the:neurochemical:mechanism</idno><idno type="wicri:Area/Main/Merge">004D91</idno><idno type="wicri:Area/Main/Curation">003708</idno><idno type="wicri:Area/Main/Exploration">003708</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The neurochemical mechanism of rebound psychosis in Parkinson's disease</title><author><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea></affiliation></author><author><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>Department of Neurology, University of Miami School of Medicine, Miami</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-04">2005-04</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="515">515</biblScope><biblScope unit="page" to="515">515</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">FE0693A54A21F8639CB502365BC025523F49A883</idno><idno type="DOI">10.1002/mds.20438</idno><idno type="ArticleID">MDS20438</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term><term>Clozapine (adverse effects)</term><term>Dibenzothiazepines (adverse effects)</term><term>Humans</term><term>Parkinson Disease (psychology)</term><term>Psychoses, Substance-Induced (etiology)</term><term>Psychotic Disorders (drug therapy)</term><term>Psychotic Disorders (etiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term><term>Clozapine</term><term>Dibenzothiazepines</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psychotic Disorders</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Psychoses, Substance-Induced</term><term>Psychotic Disorders</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Floride</li></region></list><tree><country name="États-Unis"><noRegion><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name></noRegion><name sortKey="Mash, Deborah C" sort="Mash, Deborah C" uniqKey="Mash D" first="Deborah C." last="Mash">Deborah C. Mash</name><name sortKey="Papapetropoulos, Spiridon" sort="Papapetropoulos, Spiridon" uniqKey="Papapetropoulos S" first="Spiridon" last="Papapetropoulos">Spiridon Papapetropoulos</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003708 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003708 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:FE0693A54A21F8639CB502365BC025523F49A883
|texte= The neurochemical mechanism of rebound psychosis in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |